SWEDISH BIOMIMETICS 3000 UMIST ENTERPRISE LIMITED

Executive Summary

SWEDISH BIOMIMETICS 3000 UMIST ENTERPRISE LIMITED is a dormant private limited company with minimal financial activity and nominal net assets, presenting low immediate financial risk. The company maintains good regulatory compliance with up-to-date filings, but its dormant status and lack of operational data warrant further investigation into its future business intentions and underlying value. Overall, it poses low solvency and liquidity concerns in its current state but limited insight into operational sustainability.

SWEDISH BIOMIMETICS 3000 UMIST ENTERPRISE LIMITED - Analysis Report

Company Number: 13182333

Analysis Date: 2025-07-29 17:26 UTC

1. Risk Rating: LOW
   The company is classified as dormant, with minimal financial activity and consistent filing compliance. The balance sheet shows nominal net assets and cash, indicating no outstanding liabilities or operational activity that could pose immediate risk.

2. Key Concerns:

• Dormant status means no active trading or revenue generation, raising concerns about long-term sustainability and operational viability.
• Minimal financial data (only £10 share capital and cash) provides little insight into future business prospects or solvency beyond the dormant state.
• Lack of recent operational activity may suggest the company is a holding or shell entity, requiring verification of its underlying purpose and intentions.

3. Positive Indicators:

• The company is current with all statutory filings (accounts and confirmation statements), indicating good governance and regulatory compliance.
• No overdue accounts or confirmation statements, reducing risk of penalties or regulatory action.
• Directors appear stable with no disqualifications or governance issues reported.

4. Due Diligence Notes:

• Confirm the company’s intended business model and plans for reactivation or ongoing operations.
• Investigate the relationship with Adepta Limited, the registered address, and the potential operational or financial links.
• Review any contracts, intellectual property, or arrangements underpinning the company’s value beyond the dormant accounts.